DZ Bank
CDTX

DZ Bank’s Cidara Therapeutics CDTX Stock Holding History

DZ Bank’s Portfolio CDTX Stock Details CDTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-1,773
Closed -$142K – 889
2018
Q1 		$142K Buy
+1,773
New +$242K ﹤0.01% 967

Other funds holding CDTX

BB
BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
OFM
Omega Fund Management Boston, Massachusetts $163M AUM 107.06% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
IVM
InterWest Venture Management San Francisco, California $20.6M AUM 48.5% 1-Year Est. Return
FM
Frazier Management Seattle, Washington $1.12M AUM 151.58% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return
AC
Aisling Capital New York $45.3M AUM 15.24% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

DZ Bank's CDTX Position: Q2 2018 in Review

DZ Bank sold out of Cidara Therapeutics (CDTX) in Q2 2018, closing a stake of 1,773 shares — an estimated $142K sold.

DZ Bank first reported a position in CDTX in Q1 2018 and held it in 1 quarter. The position peaked at $142K in Q1 2018. 56 funds tracked by Wall St. Rank hold CDTX as of Q2 2018.

  • DZ Bank reported no remaining Cidara Therapeutics position as of Q2 2018 after selling out during the quarter.
  • DZ Bank sold 1,773 Cidara Therapeutics shares in Q2 2018, an estimated $142K.
  • DZ Bank first reported a position in Cidara Therapeutics in Q1 2018 and held it in 1 quarter.
  • DZ Bank's Cidara Therapeutics position peaked at $142K in Q1 2018.
  • 56 funds tracked by Wall St. Rank held Cidara Therapeutics as of Q2 2018.

Based on DZ Bank's 13F filing for Q2 2018, filed 14 Aug 2018.